Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A

Gynecologic Oncology

Volumn 124, Issue 3, 2012, Pages 606-612

  Zhang, Xuan ^a   Samadi, Abbas K ^a   Roby, Katherine F ^b   Timmermann, Barbara ^c   Cohen, Mark S ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Notch; Ovarian cancer; Withaferin A

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOCORTIN 5; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; WITHAFERIN A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CLONOGENIC ASSAY; COLONY FORMATION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CDC25 PHOSPHATASES; CELL GROWTH PROCESSES; DOWN-REGULATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; ONCOGENE PROTEIN V-AKT; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, NOTCH1; RECEPTORS, NOTCH; WITHANOLIDES;

EID: 84856729767     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.11.044     Document Type: Article

References (18)

1. J.H. Choi, A.S. Wang, H.F. Huang, and P.C. Leung Gonadotropins and ovarian cancer Endocr Rev 28 2007 440 461 [PubMed: 17463396]
2. S.L. Rose Notch signaling pathway in ovarian cancer Int J Gynecol Cancer 19 2009 564 566 [PubMed:19509550]
3. S.L. Rose, M. Kunnimalaiyaan, J. Drenzek, and N. Seiler Notch 1 signaling is active in ovarian cancer Gynecol Oncol 117 2010 130 133 [PubMed: 20060575]
4. J.T. Park, M. Li, K. Nakayama, T.L. TMao, B. Davidson, and Z. Zhang Notch3 gene amplification in ovarian cancer Cancer Res 66 2006 6312 6318 [PubMed: 16778208]
5. L. Miele Notch signaling Clin Cancer Res 12 2006 1074 1079 [PubMed: 16489059]
6. P.U. Devi Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization Indian J Exp Bio 34 1996 927 932 [PubMed: 9055640]
7. Y. Yu, A. Hamza, T. Zhang, M. Gu, P. Zou, and B. Newman Withaferin A targets heat shock protein 90 in pancreatic cancer cells Biochem Pharmacol 79 2010 542 551 [PubMed: 19769945]
8. S.D. Stan, E.R. Hahm, R. Warin, and S.V. Singh Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo Cancer Res 68 2008 7661 7669 [PubMed: 18794155]
9. M. Winters Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology Altern Med Rev 11 2006 269 277 [PubMed: 17176166]
10. S. Koduru, R. Kumar, S. Srinivasan, M.B. Evers, and C. Damodaran Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis Mol Cancer Ther 9 2010 202 210 [PubMed: 20053782]
11. S.D. Stan, Y. Zeng, and S.V. Singh Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells Nutr Cancer 60 2008 51 60 [PubMed: 19003581]
12. S. Srinivasan, R.S. Ranga, R. Burikhanov, S.S. HanS, and D. Chendil Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells Cancer Res 67 2007 246 253 [PubMed: 17185378]
13. R.J. Michalides Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer J Clin Pathol 52 1999 555 568 [PubMed: 10645224]
14. L.D. Berry, and K.L. Gould Regulation of Cdc2 activity by phosphorylation at T14/Y15 Prog Cell Cycle Res 2 1996 99 105 [PubMed: 9552387]
15. F. Wolf, C. Wandke, N. Isenberg, and S. Geley Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells EMBO J 25 2006 2802 2813 [PubMed: 16724106]
16. O. Meurette, S. Stylianou, R. Rock, G.M. Collu, A.P. Gilmore, and K. Brennan Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells Cancer Res 69 2009 5015 5022 [PubMed: 19491273]
17. D.A. Altomare, H.Q. Wang, K.L. Skele, A. De Rienzo, A.J. Klein-Szanto, and A.K. Godwin AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth Oncogene 23 2004 5853 5857 [PubMed: 15208673]
18. G.B. Mills, Y. Lu, X. Fang, H. Wang, A. Eder, and M. Mao The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy Semin Oncol 28 2001 125 141 [PubMed: 11706404]